Phosphorylated derivatives of phosphatidylinositol (PI), collectively called phosphoinositides, regulate many important cellular signaling pathways. Lipid signaling disorders are linked to the development of several severe diseases in humans (1) . Consequently, there is an increasing interest in the identification of proteins that interact with these lipids. The recent discovery of phosphoinositide-binding domains such as pleckstrin homology (PH), Fab1, YOTB, Vac1, and EEA1 (FYVE), phox homology (PX), and epsin N-terminal homology (ENTH) domains (2) has sped up the discovery of proteins that bind to phosphorylated lipids. Nitrocellulose strips containing immobilized lipids have been used to assess the phosphoinositide-binding properties of proteins (3) . Likewise, phosphoinositides covalently coupled to Sepharose ® beads have been employed to identify novel lipidbinding proteins (4, 5) . However, there are several disadvantages connected with these approaches. Extensive chemical synthesis is required to obtain phosphoinositide derivatives that can be linked to affinity matrices (4, 5) . Furthermore, a high number of nonspecific binding partners usually attach to the affinity matrix as well. Binding assays that use lipids immobilized on nitrocellulose membranes often produce rather moderate affinity and low specificity associations with the immobilized lipids, which may inaccurately reflect the in vivo characteristics of a particular protein-lipid interaction (3) . Connected with these problems is the recent discovery that the binding specificities of lipid-interacting domains is not determined by their lipid-binding domains alone, but requires additional interactions (6,7). Several liposome-based assays for analyzing binding specificities of recombinant proteins have also been described (8) (9) (10) (11) (12) . However, the published examples required expression and usually immobilization of recombinant proteins on solid support. Consequently, these methods require construction of respective expression vectors, and more importantly, they are not suitable for purification or identification of additional lipid binding factors.
Here we describe a novel affinity binding protocol that uses phosphoinositide-containing liposomes as a matrix for protein binding. Different from other liposome-based assays, this method allows affinity purification of lipid-binding proteins from crude subcellular fractions. The BENCHMARKS liposomes employed in this assay contain N-biotinyl cap-phosphatidylethanolamine (BC-PE; Avanti Polar Lipids, Alabaster, AL, USA) ( Figure  1, A and B) , phosphoinositides, and additional phospholipids at concentrations mimicking the lipid distribution of cellular membranes. After incubation with cellular fractions, lipid-binding proteins attached to the liposomes can be recovered by affinity isolation using streptavidin-coupled agarose (Sigma, St. Louis, MO, USA) ( Figure 1C) . The liposome preparation used in our analysis contained 10 mg/mL of total lipid with the following composition: 60% (w/w) phosphatidylcholine, 20% (w/w) phosphatidylinositol, 10% (w/w) cholesterol (all from Sigma), and 10% (w/w) of BC-PE. Additionally, 2% (w/ w) of different phosphoinositides was added. Because the exact lipid content in commercial preparations varies, the exact amount of each individual lipid was determined by weighing using an analytical balance (after solvent evaporation if necessary) prior to liposome preparation. The combined dried lipid mixture was resuspended in liposome buffer (50 mM potassium acetate, 1 mM EDTA, 20 mM HEPES-HCl, pH 7.4). Liposome formation was induced by a 1-min ultrasonication (pulse mode, 10%) on ice using a Biosonik IV microtip sonicator (Bronwill, Rochester, NY, USA). Optionally, liposomes can then be recovered by a short centrifugation step (10 min at 2000× g) to remove heavy multilamellar liposomes. However, this step was not crucial, and in the experiments described below, liposomes were directly used after sonication.
To test this experimental approach, we expressed and extracted various lipid-binding probes from yeast cells. We used the phosphatidylinositol-4-phosphate [PI(4)P]-specific probe green fluorescent protein (GFP)-PH-FAPP1 (13), the phosphatidylinositol-4,5-bisphosphate [PI(4,5)P 2 ]-specific probe GFP-PH-PLC-∂1 (13) , and the phosphatidylinositol-3-phosphate [PI(3)P]-specific probe GFP-FYVE-EEA1 (14) . The best results were obtained with carbonate-extracted (100 mM sodium carbonate, pH 11.5) crude cellular membranes from yeast (15) , which contained the soluble lipidbinding probes without further purification. After dialyzing against 50 mM potassium acetate, 1 mM EDTA, 20 mM HEPES-HCl, pH 7.4, the extracts were incubated with liposomes containing PI(4)P (Sigma), PI(4,5)P 2 (Avanti Polar Lipids), PI(3)P (Sigma), or with control liposomes without phosphoinositides. The liposomes were then affinity purified by adding streptavidin agarose beads (Sigma) to the liposome suspension. The mixture was incubated at 4°C for 1 h followed by three washes with liposome buffer. Further analysis was performed by sodium dodecyl sulfate polyacrylamide gel electro- Liposomes were recovered by affinity purification with streptavidin agarose. Protein contents were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and by Western blot analysis using an antiserum against green fluorescent protein (GFP). The GFP-FYVE-EEA1 in our preparations migrated as two bands on SDS-PAGE. P, pellet fraction; S, supernatant fraction after streptavidin agarose pull-down. (D) A dialyzed carbonate extract from microsomal membranes was incubated with liposomes containing phosphatidylinositol-4-phosphate [PI(4)P] and BC-PE. Proteins bound to liposomes were recovered by affinity purification with streptavidin agarose, analyzed by SDS-PAGE, and stained with colloidal Coomassie Blue. The Kes1p protein was identified by mass spectrometry.
BENCHMARKS phoresis (SDS-PAGE) and immunoblotting. Binding of the different probes to the various liposomes was highly specific (Figure 2, A-C) . To test whether this method will also be applicable to identification of novel lipid binding proteins, we scaled up the liposome binding assay using PI(4)P-containing liposomes and a carbonate-extracted and dialyzed fraction enriched in peripheral microsomal proteins from yeast. After SDS-PAGE and staining with colloidal Coomassie ® Blue (Invitrogen, Carlsbad, CA, USA), we identified Kes1p as a PI(4)P-binding protein ( Figure 2D ) by mass spectrometry, which is consistent with a recent study (16) .
In summary, biotinylated liposomes are a versatile affinity matrix for identifying and analyzing phosphoinositidebinding proteins. The lipid composition that is used in liposome preparation can be varied, thus allowing the reconstitution of a membrane environment that closely resembles the one that lipidbinding proteins encounter in vivo. While this assay is useful to determine binding characteristics of known lipid-interacting factors, its major strength is in the affinity purification and identification of novel factors. To this end, cytosolic preparations or other complex protein mixtures can be used as starting material. Because some lipid-binding effectors may be of extremely low abundance, the liposomes can also be incubated with dialyzed high salt or carbonate washes from isolated cellular membranes as shown in our example ( Figure 2D ). Because distinct lipid-binding proteins are enriched at different cellular membranes, this use of extracted fractions from individual membranes may help to identify low abundant factors.
